Bio-Path Holdings, Inc. Announces Plans To Develop Liposome Tumor Targeting Technology Licensed from The University of Texas M. D. Anderson Cancer Center

BPTHPR092109

Leave a Reply

Your email address will not be published. Required fields are marked *